Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
RationaleMinocycline, a tetracycline antibiotic, interacts with brain glutamate and dopamine neurotransmission. In preclinical studies, minocycline attenuated amphetamine-induced acute dopamine release and subsequent behavioral sensitization. The goal of this study was to determine minocycline’s effects on the acute physiological, behavioral, and subjective responses to dextroamphetamine (DAMP) in healthy volunteers.MethodsTen healthy volunteers participated in an outpatient double-blind, placebo-controlled, crossover study. Subjects had a 5-day treatment period with either minocycline (200 mg/day) or placebo and then were crossed over for 5 days of the other treatment. After 2 days of taking the study medication, on days 3 and 4, subjects were randomly assigned to double-blind acute challenge with either 20 mg/70 kg DAMP or placebo DAMP (randomly labeled as drug A or B) and then crossed over to the other challenge. On day 5 (experimental session 3), subjects had the opportunity to self-administer either placebo or DAMP capsules by working on a progressive ratio computer task.ResultsMinocycline attenuated DAMP-induced subjective rewarding effects but did not change DAMP choice behavior. Minocycline treatment speeded reaction times on a Go No-Go task and reduced plasma cortisol levels.ConclusionsThese findings warrant further studies examining the potential use of minocycline for stimulant addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Tzschentke, T. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00033-2 · Cited by 481 · cited 1×
“Amphetamines activate the mesocorticolimbic dopamine system, an essential component of the brain reward circuit (Bardo 1998; Koob 1992; Tzschentke 2001 ).”
The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · cited 1×
“Further, two recent trials have utilized a 200-mg/day dose of minocycline in studies of stroke and schizophrenia (Lampl et al. 2007; Levkovitz et al. 2009; The NINDS NET-PD Investigators 2006).”
BackgroundLevkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387 · cited 3×
“Minocycline is being examined for the treatment of methamphetamine addiction, depression, schizophrenia, and neurodegenerative disorders including amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (Chaves et al. 2009; Hashimoto 2009; Levkovitz et al. 2009; Molina-Hernandez et al. 2008).”
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270 · cited 1×
“Consistent with our findings, previous studies reported dissociation between subjective drug effects and drug self-administration in humans (Dudish-Poulsen and Hatsukami 1997; Haney and Spealman 2008).”
Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors
Imbesi, M., Uz, T., Manev, R., Sharma, R. P., & Manev, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.006 · Cited by 34 · cited 6×
“In other studies, minocycline reduced glutamate release in hippocampal neurons of rats (Gonzalez et al. 2007) and increased phosphorylation and surface expression of GluR1-type AMPA receptor subunits in mouse striatal neurons (Imbesi et al. 2008).”
Influential
Cited by
Zhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538
“several animal models of neuropsychiatric disorders, including schizophrenia [46-50], depression [51] and methamphetamine (or amphetamine)-related disorders [52-56].”
Self-citationOpioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Hutchinson, M. R., Northcutt, A. L., Hiranita, T., Wang, X., Lewis, S. S., Thomas, J., van Steeg, K., Kopajtic, T. A., Loram, L. C., Sfregola, C., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0684-12.2012 · Cited by 346
Cognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 298
Self-citationGlial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
Coller, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186
Metadata
- Authors
- Sofuoglu, M., Mooney, M., Kosten, T., Waters, A., & Hashimoto, K.
- Venue
- Psychopharmacology
- Published
- 2010-09-14
- Volume
- 213
- Issue
- 1
- Pages
- 61-68
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2122483453
- Cited by
- 70
- References
- 6
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. https://app.cochat.ai/papers/10.1007/s00213-010-2014-5
- The paper
- Sofuoglu, M., Mooney, M., Kosten, T., Waters, A., & Hashimoto, K. (2011). Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Psychopharmacology. https://doi.org/10.1007/s00213-010-2014-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.